TROPHY - Candesartan Cilexetil Long-term Hypertension Prevention Trial
Public ClinicalTrials.gov record NCT00227318. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-blind, Placebo-controlled, Multicenter, Long-term Trial of Preventing Hypertension Using Candesartan Cilexetil 16 mg in Patients With High Normal Blood Pressure (TROPHY)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to determine the effectiveness of candesartan cilexetil in preventing hypertension in people with high normal blood pressure. Patients will be randomized to either Candesartan or placebo for an initial 2-year period followed by a second 2-year period of placebo for all patients.
Study identification
- NCT ID
- NCT00227318
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 1,000 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 30 Years to 65 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 1998 (Type not available)
- Primary completion
- Oct 2005 (Actual)
- Completion
- Oct 2005 (Actual)
- Last update posted
- Aug 30, 2011
1998 – 2005
United States locations
- U.S. sites
- 42
- U.S. states
- 24
- U.S. cities
- 42
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Research Site | Mobile | Alabama | — | — |
| Research Site | Long Beach | California | — | — |
| Research Site | Redondo Beach | California | — | — |
| Research Site | Santa Ana | California | — | — |
| Research Site | Tustin | California | — | — |
| Research Site | Wilmington | Delaware | — | — |
| Research Site | Washington D.C. | District of Columbia | — | — |
| Research Site | Bay Pines | Florida | — | — |
| Research Site | Gainsville | Florida | — | — |
| Research Site | Ocala | Florida | — | — |
| Research Site | Chicago | Illinois | — | — |
| Research Site | Shawnee Mission | Kansas | — | — |
| Research Site | Chelsea | Michigan | — | — |
| Research Site | Detroit | Michigan | — | — |
| Research Site | Minneapolis | Minnesota | — | — |
| Research Site | Jackson | Mississippi | — | — |
| Research Site | Florissant | Missouri | — | — |
| Research Site | Kansas City | Missouri | — | — |
| Research Site | St Louis | Missouri | — | — |
| Research Site | Buffalo | New York | — | — |
| Research Site | Rochester | New York | — | — |
| Research Site | Williamsville | New York | — | — |
| Research Site | Asheville | North Carolina | — | — |
| Research Site | Chapel Hill | North Carolina | — | — |
| Research Site | Winston-Salem | North Carolina | — | — |
| Research Site | Fargo | North Dakota | — | — |
| Research Site | Canton | Ohio | — | — |
| Research Site | Cleveland | Ohio | — | — |
| Research Site | Columbus | Ohio | — | — |
| Research Site | Oklahoma City | Oklahoma | — | — |
| Research Site | Allentown | Pennsylvania | — | — |
| Research Site | Fleetwood | Pennsylvania | — | — |
| Research Site | Pittsburgh | Pennsylvania | — | — |
| Research Site | Providence | Rhode Island | — | — |
| Research Site | Warwick | Rhode Island | — | — |
| Research Site | Charleston | South Carolina | — | — |
| Research Site | Memphis | Tennessee | — | — |
| Research Site | Dallas | Texas | — | — |
| Research Site | Houston | Texas | — | — |
| Research Site | Richmond | Virginia | — | — |
| Research Site | Morgantown | West Virginia | — | — |
| Research Site | Milwaukee | Wisconsin | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00227318, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 30, 2011 · Synced Oct 28, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00227318 live on ClinicalTrials.gov.